Drug Testing Locations - North Laurel, MD

Drug Testing in North Laurel, MD

North Laurel, Maryland Statistics

Howard County, including North Laurel, experienced a 15% increase in drug-related arrests in 2022.

In 2021, North Laurel, Howard County, reported 62 drug overdose deaths.

Substance abuse treatment admissions in Howard County, encompassing North Laurel, rose by 10% between 2021 and 2022.

Opioid prescriptions in North Laurel, part of Howard County, decreased by 8% over the past year.

Howard County, with North Laurel, saw a 20% drop in drug-related emergency room visits in 2022.

The rate of substance use disorders in North Laurel's youth population has remained steady at 5% over the last few years.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in North Laurel, MD & Drug Testing Policies

Employers in North Laurel, MD, are increasingly adopting robust drug testing policies to maintain workplace safety and productivity. Many collaborate with the Maryland Department of Labor to ensure compliance with state regulations. This includes pre-employment screenings and random testing to deter substance abuse.

Incorporating industry-specific policies, companies offer employee assistance programs for those struggling with addiction. These initiatives are instrumental in providing support and resources, reflecting a commitment to fostering a healthy work environment. Employers also emphasize education and awareness to prevent substance misuse among their workforce.

Government Efforts with Drug Problems in North Laurel, MD

The government of Howard County, including North Laurel, has initiated several programs to combat drug abuse. The Howard County Health Department actively participates in prevention and education efforts. Moreover, partnerships with state agencies help enhance treatment options and resources.

At the state level, initiatives like the Before It's Too Late program aim to address the opioid crisis and prevent addiction. These efforts are supported by federal collaborations with agencies such as the Substance Abuse and Mental Health Services Administration (SAMHSA), fostering a comprehensive approach to combating the drug epidemic in North Laurel and beyond.

Local Drug Busts & News in North Laurel, MD

Recent law enforcement operations in North Laurel, MD, have led to significant drug busts, exemplifying the ongoing battle against narcotics. In early 2023, a multi-agency task force arrested several individuals involved in a large-scale drug trafficking ring operating in and around Howard County.

These efforts have resulted in the confiscation of substantial quantities of opioids and other illegal substances. Local police, in collaboration with federal agencies, have intensified surveillance and intelligence-gathering operations to dismantle drug networks, showcasing a dedicated approach to eradicating drug-related crime in North Laurel.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in North Laurel, MD. Trusted by employers nationwide for accurate results and exceptional service.

Maryland DOT/Non DOT Physicals

Maryland Vision Tests

Maryland Audiograms

Maryland Respirator Fit Tests

Maryland Lift Tests

Maryland Background Checks

Clinical Testing Services

TB Testing in MD

Diabetes Testing in MD

Infectious Disease Testing in MD

Sickle Cell Anemia Testing in MD

Women/Men's Health Testing in MD

Resources & Citations

Johns Hopkins Howard County Substance Use Disorder Support

Baltimore County Department of Health - Substance Abuse

Suburban Hospital Substance Use Treatment

Maryland Coalition Against Sexual Assault - Substance Abuse Resources

Before It's Too Late - Maryland o-drug Crisis Efforts

Maryland Substance Abuse Support

Howard County Drug and o-drug Prevention

SAMHSA Maryland Resources

Drug Testing Near North Laurel, MD

Konterra, MD

Burtonsville, MD

Simpsonville, MD

Jessup, MD

Fulton, MD

South Laurel, MD

West Laurel, MD

Pleasant Grove, MD

Guilford, MD

Maryland City, MD

Scaggsville, MD

Laurel, MD

Savage-Guilford, MD

Savage, MD

Frequently Asked Questions

Customer Reviews